Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Randomized Trial of Esomeprazole versus Lansoprazole and Omeprazole Based Triple Therapy for H. pylori Eradication in an Iranian Population
IRCT201204043836N4Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of esomeprazole, lansoprazole and omeprazole in Helicobacter pylori infection, Peptic ulcer disease (PUD), gastritis and 1 more (3 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication rate. Started Apr 2012; status: completed.
02
Drugs
esomeprazolelansoprazoleomeprazole
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)gastritisfunctional dyspepsia (FD)
Beyond the preview
Go deeper on IRCT201204043836N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201204043836N4.